Please login to the form below

Not currently logged in


This page shows the latest Oligomannate news and features for those working in and with pharma, biotech and healthcare.

China okays Green Valley’s algae-based drug for Alzheimer’s drug

China okays Green Valley’s algae-based drug for Alzheimer’s drug

Oligomannate is the first new drug to be approved for  Alzheimer’s since memantine, which was approved in Europe in 2002 and the US in 2003. ... Green Valley says it will launch Oligomannate in China 'very soon' while also carrying out trials to

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...